Plant-made therapeutics: An emerging platform in South Africa

  • Rybicki E
  • Chikwamba R
  • Koch M
 et al. 
  • 87

    Readers

    Mendeley users who have this article in their library.
  • 15

    Citations

    Citations of this article.

Abstract

The field of plant-made therapeutics in South Africa is well established in the form of exploitation of the country's considerable natural plant diversity, both in the use of native plants in traditional herbal medicines over many centuries, and in the more modern extraction of pharmacologically-active compounds from plants, including those known to traditional healers. In recent years, this has been added to by the use of plants for the stable or transient expression of pharmaceutically-important compounds, largely protein-based biologics and vaccines. South Africa has a well-developed plant biotechnology community, as well as a comprehensive legislative framework for the regulation of the exploitation of local botanic resources, and of genetically-modified organisms. The review explores the investigation of both conventional and recombinant plants for pharmaceutical use in South Africa, as well as describing the relevant legislative and regulatory frameworks. Potential opportunities for national projects, as well as factors limiting biopharming in South Africa are discussed. © 2011.

Author-supplied keywords

  • Biopharming
  • Biosafety
  • Plant-made therapeutics
  • South Africa
  • Transgenic plants
  • Vaccines

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Edward P. Rybicki

  • Rachel Chikwamba

  • Muffy Koch

  • James I. Rhodes

  • Jan Hendrik Groenewald

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free